Advertisement
At these conferences, Company management will provide insight aboutSomanetics' business strategy and its recent financial results. Thepresentations will be webcast live. The webcasts may be accessed by visitingthe Investor Relations section of Somanetics' website at www.somanetics.com.The presentations also will be archived on Somanetics' website for 30 daysfollowing the conferences.
Advertisement
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and marketsthe INVOS(R) Cerebral/Somatic Oximeter System, a non-invasive patientmonitoring system that continuously measures changes in the blood oxygenlevels in the brain and elsewhere in the body in somatic, or skeletal muscle,tissue in patients with or at risk for restricted blood flow. Surgeons,anesthesiologists and other medical professionals can use the informationprovided by the INVOS System, in conjunction with other available information,to identify brain oxygen imbalances and take necessary corrective action,potentially improving patient outcomes and reducing the costs of care.Somanetics supports its customers through a direct U.S. sales force andclinical education team. Tyco Healthcare markets INVOS System products inEurope, Canada, the Middle East and Africa and Edwards Lifesciences representsINVOS System products in Japan. For more information visitwww.somanetics.com.-- Maxim Group Growth Conference Thursday, September 20, 2007 8:30 a.m. (ET) Grand Hyatt, New York, NY Speaker: William M. Iacona, Somanetics' chief financial officer -- UBS Global Life Sciences Conference Wednesday, September 26, 2007 8:00 a.m. (ET) Grand Hyatt, New York, NY Speaker: Bruce J. Barrett, Somanetics' president and chief executive officer
SOURCE Somanetics Corporation
